메뉴 건너뛰기




Volumn 14, Issue 1, 2015, Pages

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis

Author keywords

Atherosclerosis; Cardiovascular disease; Insulin resistance; Metabolic syndrome; Nonalcoholic fatty liver disease

Indexed keywords

ADIPOCYTOKINE; FATTY ACID BINDING PROTEIN; FETUIN A; MATRIX METALLOPROTEINASE;

EID: 84949671299     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0141-z     Document Type: Review
Times cited : (50)

References (131)
  • 1
    • 0038644536 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference
    • 12717402
    • Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37(5):1202-19.
    • (2003) Hepatology , vol.37 , Issue.5 , pp. 1202-1219
    • Neuschwander-Tetri, B.A.1    Caldwell, S.H.2
  • 2
    • 0036103602 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease
    • 12000605
    • Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17(Suppl):S186-90.
    • (2002) J Gastroenterol Hepatol , vol.17 , pp. S186-S190
    • Angulo, P.1    Lindor, K.D.2
  • 3
    • 34547491854 scopus 로고    scopus 로고
    • Obesity and nonalcoholic fatty liver disease
    • 17605315
    • Angulo P. Obesity and nonalcoholic fatty liver disease. Nutr Rev. 2007;65(6 Pt 2):S57-63.
    • (2007) Nutr Rev , vol.65 , Issue.6 PART 2 , pp. S57-S63
    • Angulo, P.1
  • 4
    • 77950323927 scopus 로고    scopus 로고
    • Pathogenesis of non-alcoholic fatty liver disease
    • 2810391 1:STN:280:DC%2BC3c%2FjvFGhtA%3D%3D 19914930
    • Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103(2):71-83.
    • (2010) QJM , vol.103 , Issue.2 , pp. 71-83
    • Dowman, J.K.1    Tomlinson, J.W.2    Newsome, P.N.3
  • 5
    • 84859448472 scopus 로고    scopus 로고
    • Metabolic syndrome and risk factors for non-alcoholic fatty liver disease
    • 22481692
    • Souza MR, Diniz Mde F, Medeiros-Filho JE, Araújo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012;49(1):89-96.
    • (2012) Arq Gastroenterol , vol.49 , Issue.1 , pp. 89-96
    • Souza, M.R.1    Diniz Mde, F.2    Medeiros-Filho, J.E.3    Araújo, M.S.4
  • 6
    • 34250326350 scopus 로고    scopus 로고
    • Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary
    • 17565629
    • Farrell GC, Chitturi S, Lau GK, Sollano JD. Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775-7.
    • (2007) J Gastroenterol Hepatol , vol.22 , Issue.6 , pp. 775-777
    • Farrell, G.C.1    Chitturi, S.2    Lau, G.K.3    Sollano, J.D.4
  • 7
    • 56949097660 scopus 로고    scopus 로고
    • Epidemiology of non-alcoholic fatty liver disease in China
    • 19014878
    • Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50(1):204-10.
    • (2009) J Hepatol , vol.50 , Issue.1 , pp. 204-210
    • Fan, J.G.1    Farrell, G.C.2
  • 8
    • 84866539263 scopus 로고    scopus 로고
    • Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: The Shanghai Changfeng study
    • 1:CAS:528:DC%2BC38XhtF2gur%2FL 22884916
    • Li X, Xia M, Ma H, Hofman A, Hu Y, Yan H, et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. Atherosclerosis. 2012;224(2):480-5.
    • (2012) Atherosclerosis , vol.224 , Issue.2 , pp. 480-485
    • Li, X.1    Xia, M.2    Ma, H.3    Hofman, A.4    Hu, Y.5    Yan, H.6
  • 9
    • 84873412907 scopus 로고    scopus 로고
    • Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation
    • 1:CAS:528:DC%2BC3sXmtFajsrc%3D 23190373
    • Akin L, Kurtoglu S, Yikilmaz A, Kendirci M, Elmall F, Mazicioglu M, et al. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatr. 2013;102(3):e107-13.
    • (2013) Acta Paediatr , vol.102 , Issue.3 , pp. e107-e113
    • Akin, L.1    Kurtoglu, S.2    Yikilmaz, A.3    Kendirci, M.4    Elmall, F.5    Mazicioglu, M.6
  • 10
    • 84861591910 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology
    • 22656328
    • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american gastroenterological association, american association for the study of liver diseases, and american college of gastroenterology. Gastroenterology. 2012;142(7):1592-609.
    • (2012) Gastroenterology , vol.142 , Issue.7 , pp. 1592-1609
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3    Diehl, A.M.4    Brunt, E.M.5    Cusi, K.6
  • 11
    • 84872062920 scopus 로고    scopus 로고
    • Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease
    • Kucukazman M, Ata N, Yavuz B, Dal K, Sen O, Deveci OS, et al. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2013;25(2):147-51.
    • (2013) Eur J Gastroenterol Hepatol , vol.25 , Issue.2 , pp. 147-151
    • Kucukazman, M.1    Ata, N.2    Yavuz, B.3    Dal, K.4    Sen, O.5    Deveci, O.S.6
  • 12
    • 37549047145 scopus 로고    scopus 로고
    • Fatty liver: A novel component of the metabolic syndrome
    • 1:CAS:528:DC%2BD2sXhsVeiu7nI 17690317
    • Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(1):27-38.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.1 , pp. 27-38
    • Kotronen, A.1    Yki-Jarvinen, H.2
  • 13
    • 84923918979 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
    • 25739820
    • Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015;47(3):181-90.
    • (2015) Dig Liver Dis , vol.47 , Issue.3 , pp. 181-190
    • Lonardo, A.1    Ballestri, S.2    Marchesini, G.3    Angulo, P.4    Loria, P.5
  • 14
    • 56649083495 scopus 로고    scopus 로고
    • Mechanisms of disease progression in nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BD1cXhsVKisr7M 18956293
    • Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370-9.
    • (2008) Semin Liver Dis , vol.28 , Issue.4 , pp. 370-379
    • Jou, J.1    Choi, S.S.2    Diehl, A.M.3
  • 15
    • 78049522194 scopus 로고    scopus 로고
    • Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
    • 1:CAS:528:DC%2BC3cXhsFOnsrjP 21038418
    • Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-46.
    • (2010) Hepatology , vol.52 , Issue.5 , pp. 1836-1846
    • Tilg, H.1    Moschen, A.R.2
  • 16
    • 33747426269 scopus 로고    scopus 로고
    • Morphological aspects of atherosclerosis lesion: Past and present
    • 1:STN:280:DC%2BD28zpvVSksw%3D%3D 16817503
    • Gaudio E, Carpino G, Grassi M, Musca A. Morphological aspects of atherosclerosis lesion: past and present. Clin Ter. 2006;157(2):135-42.
    • (2006) Clin ter , vol.157 , Issue.2 , pp. 135-142
    • Gaudio, E.1    Carpino, G.2    Grassi, M.3    Musca, A.4
  • 17
    • 0034019601 scopus 로고    scopus 로고
    • Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
    • 1:STN:280:DC%2BD3c3ntVCntA%3D%3D 10807742
    • Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262-75.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , Issue.5 , pp. 1262-1275
    • Virmani, R.1    Kolodgie, F.D.2    Burke, A.P.3    Farb, A.4    Schwartz, S.M.5
  • 18
    • 84887393203 scopus 로고    scopus 로고
    • Study of coronary atherosclerosis by modified American Heart Association classification of atherosclerosis-an autopsy study
    • 3879834 24392381
    • Bhanvadia VM, Desai NJ, Agarwal NM. Study of coronary atherosclerosis by modified american heart association classification of atherosclerosis-an autopsy study. J Clin Diagn Res. 2013;7(11):2494-7.
    • (2013) J Clin Diagn Res , vol.7 , Issue.11 , pp. 2494-2497
    • Bhanvadia, V.M.1    Desai, N.J.2    Agarwal, N.M.3
  • 19
    • 17644412023 scopus 로고    scopus 로고
    • Inflammation, atherosclerosis, and coronary artery disease
    • 1:CAS:528:DC%2BD2MXjsFCltrc%3D 15843671
    • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-95.
    • (2005) N Engl J Med , vol.352 , Issue.16 , pp. 1685-1695
    • Hansson, G.K.1
  • 20
    • 84941269822 scopus 로고    scopus 로고
    • Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease
    • Silaghi CA, Silaghi H, Crəciun AE, FərcaĚ A, Colosi HA, Cosma DT, et al. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. Med Ultrason. 2015;17(3):300-7.
    • (2015) Med Ultrason , vol.17 , Issue.3 , pp. 300-307
    • Silaghi, C.A.1
  • 21
    • 33947108446 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
    • 1:CAS:528:DC%2BD2sXjtFGrur8%3D 16970951
    • Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191:235-40.
    • (2007) Atherosclerosis , vol.191 , pp. 235-240
    • Targher, G.1    Arcaro, G.2
  • 22
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease andits association with cardiovascular disease among type 2 diabetic patients
    • 17277038
    • Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease andits association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212-8.
    • (2007) Diabetes Care , vol.30 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Rodella, S.4    Tessari, R.5    Zenari, L.6
  • 23
    • 77957375969 scopus 로고    scopus 로고
    • Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BC3cXht1Wqt7vO 20879883
    • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341-50.
    • (2010) N Engl J Med , vol.363 , pp. 1341-1350
    • Targher, G.1    Day, C.P.2    Bonora, E.3
  • 24
    • 77956266803 scopus 로고    scopus 로고
    • Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
    • 1:CAS:528:DC%2BC3cXhtV2gtbnE 20619918
    • Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol. 2010;53:713-8.
    • (2010) J Hepatol , vol.53 , pp. 713-718
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Rodella, S.4    Zoppini, G.5    Pichiri, I.6
  • 25
    • 84877854022 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
    • 3708335 1:CAS:528:DC%2BC3sXosVSmtbg%3D 23666091
    • Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A, et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5:1544-60.
    • (2013) Nutrients , vol.5 , pp. 1544-1560
    • Gaggini, M.1    Morelli, M.2    Buzzigoli, E.3    DeFronzo, R.A.4    Bugianesi, E.5    Gastaldelli, A.6
  • 26
    • 84855937154 scopus 로고    scopus 로고
    • NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
    • Bieghs V, Rensen PC, Hofker MH, Shiri-Sverdlov R. NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis. 2012;220:287-93.
    • (2012) Atherosclerosis , vol.220 , pp. 287-293
    • Bieghs, V.1    Rensen, P.C.2    Hofker, M.H.3    Shiri-Sverdlov, R.4
  • 29
    • 0037153063 scopus 로고    scopus 로고
    • Intima-media thickness: A tool for atherosclerosis imaging and event prediction
    • 12459422
    • O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002;90:18L-21L.
    • (2002) Am J Cardiol , vol.90 , pp. 18L-21L
    • O'Leary, D.H.1    Polak, J.F.2
  • 30
    • 84942763280 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: A meta-analysis
    • 1:CAS:528:DC%2BC2MXhs1Sis7nO
    • Madan SA, John F, Pyrsopoulos N, Pitchumoni CS. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis. Eur J Gastroentreol Hepatol. 2015;27(11):1237-48.
    • (2015) Eur J Gastroentreol Hepatol , vol.27 , Issue.11 , pp. 1237-1248
    • Madan, S.A.1    John, F.2    Pyrsopoulos, N.3    Pitchumoni, C.S.4
  • 31
    • 35348845091 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
    • 1:STN:280:DC%2BD2snit1eitw%3D%3D 17560098
    • Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N, et al. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis. 2007;17(9):684-98.
    • (2007) Nutr Metab Cardiovasc Dis , vol.17 , Issue.9 , pp. 684-698
    • Loria, P.1    Lonardo, A.2    Bellentani, S.3    Day, C.P.4    Marchesini, G.5    Carulli, N.6
  • 32
    • 84878930738 scopus 로고    scopus 로고
    • Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
    • 1:CAS:528:DC%2BC3sXptVOlsrs%3D 23507799
    • Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10(6):330-44.
    • (2013) Nat Rev Gastroenterol Hepatol , vol.10 , Issue.6 , pp. 330-344
    • Anstee, Q.M.1    Targher, G.2    Day, C.P.3
  • 33
    • 34247647418 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    • 4146902 1:CAS:528:DC%2BD2sXlslKqtL8%3D 17461452
    • Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10):1579-84.
    • (2007) World J Gastroenterol , vol.13 , Issue.10 , pp. 1579-1584
    • Hamaguchi, M.1    Kojima, T.2    Takeda, N.3    Nagata, C.4    Takeda, J.5    Sarui, H.6
  • 34
    • 84877734956 scopus 로고    scopus 로고
    • Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis
    • 1:CAS:528:DC%2BC3sXnsFSntr4%3D 23475581
    • Gupte AA, Lyon CJ, Hsueh WA. Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr Diab Rep. 2013;13(3):362-71.
    • (2013) Curr Diab Rep , vol.13 , Issue.3 , pp. 362-371
    • Gupte, A.A.1    Lyon, C.J.2    Hsueh, W.A.3
  • 35
    • 84867650500 scopus 로고    scopus 로고
    • Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease
    • Severova MM, Saginova EA, Galliamov MG, Ermakov NV, Rodina AV, Fomin VV, et al. Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease. Ter Arkh. 2012;84(6):15-20.
    • (2012) Ter Arkh , vol.84 , Issue.6 , pp. 15-20
    • Severova, M.M.1    Saginova, E.A.2    Galliamov, M.G.3    Ermakov, N.V.4    Rodina, A.V.5    Fomin, V.V.6
  • 36
    • 67649429268 scopus 로고    scopus 로고
    • Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BD1MXlsFWrt7s%3D 19360318
    • Nakamuta M, Fujino T, Yada R, Yada M, Yasutake Y, Yoshimoto T, et al. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med. 2009;23(5):603-8.
    • (2009) Int J Mol Med , vol.23 , Issue.5 , pp. 603-608
    • Nakamuta, M.1    Fujino, T.2    Yada, R.3    Yada, M.4    Yasutake, Y.5    Yoshimoto, T.6
  • 37
    • 77956504365 scopus 로고    scopus 로고
    • Atherosclerosis regression and high-density lipoproteins
    • 1:CAS:528:DC%2BC3cXhtFChtL%2FK 20828355
    • Lee JM, Choudhury RP. Atherosclerosis regression and high-density lipoproteins. Expert Rev Cardiovasc Ther. 2010;8(9):1325-34.
    • (2010) Expert Rev Cardiovasc Ther , vol.8 , Issue.9 , pp. 1325-1334
    • Lee, J.M.1    Choudhury, R.P.2
  • 39
    • 4444302652 scopus 로고    scopus 로고
    • Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis
    • 1:CAS:528:DC%2BD2cXnsFWnurw%3D 15320816
    • Gouni-Berthold I, Sachinidis A. Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis. Curr Vasc Pharmacol. 2004;2(4):363-70.
    • (2004) Curr Vasc Pharmacol , vol.2 , Issue.4 , pp. 363-370
    • Gouni-Berthold, I.1    Sachinidis, A.2
  • 40
    • 75449094816 scopus 로고    scopus 로고
    • Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
    • 3575093 1:CAS:528:DC%2BC3cXisVGnsrk%3D 20041406
    • Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-89.
    • (2010) Hepatology , vol.51 , Issue.2 , pp. 679-689
    • Fabbrini, E.1    Sullivan, S.2    Klein, S.3
  • 41
    • 50449086746 scopus 로고    scopus 로고
    • Obesity and free fatty acids
    • 2596919 1:CAS:528:DC%2BD1cXht1Kqs77J 18775356
    • Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008;37(3):635-46.
    • (2008) Endocrinol Metab Clin North Am , vol.37 , Issue.3 , pp. 635-646
    • Boden, G.1
  • 42
    • 33750823407 scopus 로고    scopus 로고
    • Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates
    • Solinas G, Naugler W, Galimi F, Lee MS, Karin M, et al. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A. 2006;103(44):16454-9.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.44 , pp. 16454-16459
    • Solinas, G.1    Naugler, W.2    Galimi, F.3    Lee, M.S.4    Karin, M.5
  • 43
    • 13844296360 scopus 로고    scopus 로고
    • Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat
    • 1:CAS:528:DC%2BD2MXhtlOmtLs%3D 15721008
    • Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis. 2005;179(1):43-9.
    • (2005) Atherosclerosis , vol.179 , Issue.1 , pp. 43-49
    • Delbosc, S.1    Paizanis, E.2    Magous, R.3    Araiz, C.4    Dimo, T.5    Cristol, J.P.6
  • 44
    • 78449282359 scopus 로고    scopus 로고
    • Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment
    • 1:CAS:528:DC%2BC3cXhsVGntrnO 20813110
    • Carreau A, Kieda C, Grillon C. Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment. Exp Cell Res. 2011;317(1):29-41.
    • (2011) Exp Cell Res , vol.317 , Issue.1 , pp. 29-41
    • Carreau, A.1    Kieda, C.2    Grillon, C.3
  • 45
    • 68349135431 scopus 로고    scopus 로고
    • NO/peroxynitrite dynamics of high glucose-exposed HUVECs: Chemiluminescent measurement and computational model
    • 19
    • Potdar S, Kavdia M. NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model. Microvasc Res. 2009;78(2):1-8. 19.
    • (2009) Microvasc Res , vol.78 , Issue.2 , pp. 1-8
    • Potdar, S.1    Kavdia, M.2
  • 46
    • 33947162483 scopus 로고    scopus 로고
    • Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis
    • Xi H, Akishita M, Nagai K, Yu W, Hasegawa H, Eto M, et al. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis. 2007;191(2):281-9.
    • (2007) Atherosclerosis , vol.191 , Issue.2 , pp. 281-289
    • Xi, H.1    Akishita, M.2    Nagai, K.3    Yu, W.4    Hasegawa, H.5    Eto, M.6
  • 47
    • 77955270623 scopus 로고    scopus 로고
    • Dihydrotestosterone protects human vascular endothelial cells from H(2)O(2)-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK
    • 1:CAS:528:DC%2BC3cXps1aqsb8%3D 20599910
    • Xu ZR, Hu L, Cheng LF, Qian Y, Yang YM. Dihydrotestosterone protects human vascular endothelial cells from H(2)O(2)-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK. Eur J Pharmacol. 2010;643(2-3):254-9.
    • (2010) Eur J Pharmacol , vol.643 , Issue.2-3 , pp. 254-259
    • Xu, Z.R.1    Hu, L.2    Cheng, L.F.3    Qian, Y.4    Yang, Y.M.5
  • 48
    • 79955640814 scopus 로고    scopus 로고
    • Reactive oxygen species and oxidative stress
    • Migdal C, Serres M. Reactive oxygen species and oxidative stress. Med Sci (Paris). 2011;27(4):405-12.
    • (2011) Med Sci (Paris) , vol.27 , Issue.4 , pp. 405-412
    • Migdal, C.1    Serres, M.2
  • 49
    • 77951736264 scopus 로고    scopus 로고
    • Vascular oxidative stress: The common link in hypertensive and diabetic vascular disease
    • 3018745 1:CAS:528:DC%2BC3cXltVWltLs%3D 20422735
    • Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol. 2010;55(4):308-16.
    • (2010) J Cardiovasc Pharmacol , vol.55 , Issue.4 , pp. 308-316
    • Cohen, R.A.1    Tong, X.2
  • 50
    • 84855597740 scopus 로고    scopus 로고
    • Endoplasmic reticulum stress and lipid metabolism: Mechanisms and therapeutic potential
    • 3238353 22195283
    • Basseri S, Austin RC. Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential. Biochem Res Int. 2012;2012:841362.
    • (2012) Biochem Res Int , vol.2012 , pp. 841362
    • Basseri, S.1    Austin, R.C.2
  • 51
    • 77952480033 scopus 로고    scopus 로고
    • Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis
    • 2825658 20182627
    • Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010;2010:453892.
    • (2010) Mediators Inflamm , vol.2010 , pp. 453892
    • Kaneto, H.1    Katakami, N.2    Matsuhisa, M.3    Matsuoka, T.A.4
  • 52
    • 14644427890 scopus 로고    scopus 로고
    • Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
    • Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11(2):183-90.
    • (2005) Nat Med , vol.11 , Issue.2 , pp. 183-190
    • Cai, D.1    Yuan, M.2    Frantz, D.F.3    Melendez, P.A.4    Hansen, L.5    Lee, J.6
  • 53
    • 77951181327 scopus 로고    scopus 로고
    • Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure
    • 2836069 1:CAS:528:DC%2BC3cXhs1aksrk%3D 20018865
    • Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Jung DY, et al. Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem. 2010;285(7):4637-44.
    • (2010) J Biol Chem , vol.285 , Issue.7 , pp. 4637-4644
    • Tang, T.1    Zhang, J.2    Yin, J.3    Staszkiewicz, J.4    Gawronska-Kozak, B.5    Jung, D.Y.6
  • 54
    • 33646161443 scopus 로고    scopus 로고
    • Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
    • 1:CAS:528:DC%2BD28XksVaitr8%3D 16618517
    • Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167-74.
    • (2006) J Hepatol , vol.44 , Issue.6 , pp. 1167-1174
    • Haukeland, J.W.1    Damås, J.K.2    Konopski, Z.3    Løberg, E.M.4    Haaland, T.5    Goverud, I.6
  • 55
    • 70350450885 scopus 로고    scopus 로고
    • How much is too much? Interleukin-6 and its signalling in atherosclerosis
    • 1:CAS:528:DC%2BD1MXhtVGhsL3E 19652871
    • Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B, et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost. 2009;102(2):215-22.
    • (2009) Thromb Haemost , vol.102 , Issue.2 , pp. 215-222
    • Schuett, H.1    Luchtefeld, M.2    Grothusen, C.3    Grote, K.4    Schieffer, B.5
  • 56
    • 42449097289 scopus 로고    scopus 로고
    • Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
    • 2886982 1:CAS:528:DC%2BD1cXkvF2gt7k%3D 18401346
    • Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367-77.
    • (2008) Nat Rev Mol Cell Biol , vol.9 , Issue.5 , pp. 367-377
    • Guilherme, A.1    Virbasius, J.V.2    Puri, V.3    Czech, M.P.4
  • 57
    • 84872543846 scopus 로고    scopus 로고
    • Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases
    • Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, et al. Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases. Biomarkers. 2013;18(1):82-7.
    • (2013) Biomarkers , vol.18 , Issue.1 , pp. 82-87
    • Toyoda, H.1    Kumada, T.2    Kiriyama, S.3    Tanikawa, M.4    Hisanaga, Y.5    Kanamori, A.6
  • 58
    • 77952049390 scopus 로고    scopus 로고
    • The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
    • 1:CAS:528:DC%2BC3cXmslCiur4%3D 20415685
    • Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab. 2010;12(5):365-83.
    • (2010) Diabetes Obes Metab , vol.12 , Issue.5 , pp. 365-383
    • Polyzos, S.A.1    Kountouras, J.2    Zavos, C.3    Tsiaousi, E.4
  • 59
    • 84908142654 scopus 로고    scopus 로고
    • Adiponectin abates atherosclerosis by reducing oxidative stress
    • Wang X, Pu H, Ma C, Jiang T, Wei Q, Zhang C, et al. Adiponectin abates atherosclerosis by reducing oxidative stress. Med Sci Monit. 2014;20:1792-800.
    • (2014) Med Sci Monit , vol.20 , pp. 1792-1800
    • Wang, X.1    Pu, H.2    Ma, C.3    Jiang, T.4    Wei, Q.5    Zhang, C.6
  • 60
    • 67349107196 scopus 로고    scopus 로고
    • Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population
    • 1:CAS:528:DC%2BD1MXnsFagsbk%3D 19118830
    • Hansen T, Ahlström H, Söderberg S, Hulthe J, Wikström J, Lind L, et al. Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population. Atherosclerosis. 2009;205(1):163-7.
    • (2009) Atherosclerosis , vol.205 , Issue.1 , pp. 163-167
    • Hansen, T.1    Ahlström, H.2    Söderberg, S.3    Hulthe, J.4    Wikström, J.5    Lind, L.6
  • 61
    • 0842267585 scopus 로고    scopus 로고
    • NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: Potential implication in plaque instability
    • Martín-Ventura JL, Blanco-Colio LM, Muñoz-García B, Gómez-Hernández A, Arribas A, Ortega L, et al. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke. 2004;35(2):458-63.
    • (2004) Stroke , vol.35 , Issue.2 , pp. 458-463
    • Martín-Ventura Jl, B.1
  • 62
    • 78449263202 scopus 로고    scopus 로고
    • Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD
    • 1:CAS:528:DC%2BC3cXht1Wjtb7M 20808246
    • Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr. 2010;51(4):500-6.
    • (2010) J Pediatr Gastroenterol Nutr , vol.51 , Issue.4 , pp. 500-506
    • Fitzpatrick, E.1    Mitry, R.R.2    Quaglia, A.3    Hussain, M.J.4    DeBruyne, R.5    Dhawan, A.6
  • 63
    • 84863508993 scopus 로고    scopus 로고
    • Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling
    • 1:CAS:528:DC%2BC38XpvFGnu70%3D 22768838
    • Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, et al. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab. 2012;16(1):44-54.
    • (2012) Cell Metab , vol.16 , Issue.1 , pp. 44-54
    • Imajo, K.1    Fujita, K.2    Yoneda, M.3    Nozaki, Y.4    Ogawa, Y.5    Shinohara, Y.6
  • 64
    • 84862326895 scopus 로고    scopus 로고
    • Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats
    • Kwon DH, Kang W, Nam YS, Lee MS, Lee IY, Kim HJ, et al. Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats. J Nutr Biochem. 2012;23(7):791-9.
    • (2012) J Nutr Biochem , vol.23 , Issue.7 , pp. 791-799
    • Kwon, D.H.1    Kang, W.2    Nam, Y.S.3    Lee, M.S.4    Lee, I.Y.5    Kim, H.J.6
  • 65
    • 0036091969 scopus 로고    scopus 로고
    • Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway
    • 1:CAS:528:DC%2BD38Xlt1ehsQ%3D%3D 11756337
    • Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51(1):168-73.
    • (2002) Diabetes , vol.51 , Issue.1 , pp. 168-173
    • Vecchione, C.1    Maffei, A.2    Colella, S.3    Aretini, A.4    Poulet, R.5    Frati, G.6
  • 66
    • 7044222808 scopus 로고    scopus 로고
    • Plasma leptin and prognosis in patients with established coronary atherosclerosis
    • 1:CAS:528:DC%2BD2cXptFOmt7Y%3D 15519013
    • Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004;44(9):1819-24.
    • (2004) J Am Coll Cardiol , vol.44 , Issue.9 , pp. 1819-1824
    • Wolk, R.1    Berger, P.2    Lennon, R.J.3    Brilakis, E.S.4    Johnson, B.D.5    Somers, V.K.6
  • 67
    • 84949680511 scopus 로고    scopus 로고
    • The expression and meaning of Visfatin in nonalcoholic fatty liver disease rat liver tissue
    • 1:CAS:528:DC%2BC2MXhtFGju7fO
    • Xu H, Deng Y. The expression and meaning of Visfatin in nonalcoholic fatty liver disease rat liver tissue. J Chin Physician. 2014;16(5):616-9.
    • (2014) J Chin Physician , vol.16 , Issue.5 , pp. 616-619
    • Xu, H.1    Deng, Y.2
  • 68
    • 33847279330 scopus 로고    scopus 로고
    • Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: Possible role in inflammation and plaque destabilization
    • 1:CAS:528:DC%2BD2sXhvVyquro%3D 17283255
    • Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation. 2007;115(8):972-80.
    • (2007) Circulation , vol.115 , Issue.8 , pp. 972-980
    • Dahl, T.B.1    Yndestad, A.2    Skjelland, M.3    Øie, E.4    Dahl, A.5    Michelsen, A.6
  • 69
    • 84862647160 scopus 로고    scopus 로고
    • The association of serum chemerin level with risk of coronary artery disease in Chinese adults
    • Yan Q, Zhang Y, Hong J, Gu W, Dai M, Shi J, et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine. 2012;41(2):281-8.
    • (2012) Endocrine , vol.41 , Issue.2 , pp. 281-288
    • Yan, Q.1    Zhang, Y.2    Hong, J.3    Gu, W.4    Dai, M.5    Shi, J.6
  • 70
    • 69049111026 scopus 로고    scopus 로고
    • Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
    • Wang CC, Lin SK, Tseng YF, Hsu CS, Tseng TC, Lin HH, et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24(8):1411-6.
    • (2009) J Gastroenterol Hepatol , vol.24 , Issue.8 , pp. 1411-1416
    • Wang, C.C.1    Lin, S.K.2    Tseng, Y.F.3    Hsu, C.S.4    Tseng, T.C.5    Lin, H.H.6
  • 71
    • 84868316900 scopus 로고    scopus 로고
    • Serum retinol-binding protein 4 as a marker for cardiovascular disease in women
    • 3485358 1:CAS:528:DC%2BC38XhslWjsb%2FO 23119072
    • Alkharfy KM, Al-Daghri NM, Vanhoutte PM, Krishnaswamy S, Xu A. Serum retinol-binding protein 4 as a marker for cardiovascular disease in women. PLoS One. 2012;7(10):e48612.
    • (2012) PLoS One , vol.7 , Issue.10 , pp. e48612
    • Alkharfy, K.M.1    Al-Daghri, N.M.2    Vanhoutte, P.M.3    Krishnaswamy, S.4    Xu, A.5
  • 72
    • 0037053677 scopus 로고    scopus 로고
    • Effect of recombinant human growth hormone on postoperative fatigue syndrome in patients after cardiac operations
    • 1:CAS:528:DC%2BD38Xptlygsbs%3D 12126548
    • Mao Z, Chen R, Zhao L. Effect of recombinant human growth hormone on postoperative fatigue syndrome in patients after cardiac operations. Zhonghua Yi Xue Za Zhi. 2002;82(11):762-5.
    • (2002) Zhonghua Yi Xue Za Zhi , vol.82 , Issue.11 , pp. 762-765
    • Mao, Z.1    Chen, R.2    Zhao, L.3
  • 73
    • 33745095399 scopus 로고    scopus 로고
    • Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
    • Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552-63.
    • (2006) N Engl J Med , vol.354 , Issue.24 , pp. 2552-2563
    • Graham, Y.1
  • 74
    • 83455164042 scopus 로고    scopus 로고
    • Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue
    • 1:CAS:528:DC%2BC38XhsVagtL4%3D
    • Salgado-Somoza A, Teijeira-Fernández E, Rubio J, Couso E, González-Juanatey JR, Eiras S, et al. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf). 2012;76(1):51-8.
    • (2012) Clin Endocrinol (Oxf) , vol.76 , Issue.1 , pp. 51-58
    • Salgado-Somoza, A.1    Teijeira-Fernández, E.2    Rubio, J.3    Couso, E.4    González-Juanatey, J.R.5    Eiras, S.6
  • 75
    • 77949484644 scopus 로고    scopus 로고
    • Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels
    • 1:CAS:528:DC%2BC3cXjs1Ont74%3D 20170632
    • Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393(4):668-72.
    • (2010) Biochem Biophys Res Commun , vol.393 , Issue.4 , pp. 668-672
    • Yamawaki, H.1    Tsubaki, N.2    Mukohda, M.3    Okada, M.4    Hara, Y.5
  • 76
    • 84859009706 scopus 로고    scopus 로고
    • Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction
    • 1:CAS:528:DC%2BC38Xnt1ylurk%3D 22449228
    • Yu M, Ishibashi-Ueda H, Ohta-Ogo K, Gabbiani G, Yamagishi M, Hayashi K, et al. Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction. Pathol Int. 2012;62(4):246-53.
    • (2012) Pathol Int , vol.62 , Issue.4 , pp. 246-253
    • Yu, M.1    Ishibashi-Ueda, H.2    Ohta-Ogo, K.3    Gabbiani, G.4    Yamagishi, M.5    Hayashi, K.6
  • 77
    • 33644825288 scopus 로고    scopus 로고
    • Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
    • 1:CAS:528:DC%2BD28Xis1Cmurk%3D 16394091
    • Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab. 2006;91(3):1081-6.
    • (2006) J Clin Endocrinol Metab , vol.91 , Issue.3 , pp. 1081-1086
    • Pagano, C.1    Soardo, G.2    Pilon, C.3    Milocco, C.4    Basan, L.5    Milan, G.6
  • 78
    • 73949125986 scopus 로고    scopus 로고
    • Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells
    • 1:CAS:528:DC%2BC3cXot1ynsQ%3D%3D 20034466
    • Manduteanu I, Pirvulescu M, Gan AM, Stan D, Simion V, Dragomir E, et al. Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells. Biochem Biophys Res Commun. 2010;391(3):1443-8.
    • (2010) Biochem Biophys Res Commun , vol.391 , Issue.3 , pp. 1443-1448
    • Manduteanu, I.1    Pirvulescu, M.2    Gan, A.M.3    Stan, D.4    Simion, V.5    Dragomir, E.6
  • 79
    • 23044439100 scopus 로고    scopus 로고
    • Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway
    • 1:CAS:528:DC%2BD2MXntVOisbo%3D 16039994
    • Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334(4):1092-101.
    • (2005) Biochem Biophys Res Commun , vol.334 , Issue.4 , pp. 1092-1101
    • Silswal, N.1    Singh, A.K.2    Aruna, B.3    Mukhopadhyay, S.4    Ghosh, S.5    Ehtesham, N.Z.6
  • 80
    • 17644367457 scopus 로고    scopus 로고
    • Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial infarction
    • Pandian S, Amuthan V, Sukumar P, Janarthanan RA, Murugan S, Palanichamy S, et al. Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial infarction. Indian Heart J. 2005;57(1):54-7.
    • (2005) Indian Heart J. , vol.57 , Issue.1 , pp. 54-57
    • Pandian, S.1    Amuthan, V.2    Sukumar, P.3    Janarthanan, R.A.4    Murugan, S.5    Palanichamy, S.6
  • 81
    • 29144432822 scopus 로고    scopus 로고
    • Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
    • Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res. 2006;69(1):76-85.
    • (2006) Cardiovasc Res , vol.69 , Issue.1 , pp. 76-85
    • Jung, H.S.1    Park, K.H.2    Cho, Y.M.3    Chung, S.S.4    Cho, H.J.5    Cho, S.Y.6
  • 82
    • 9344252820 scopus 로고    scopus 로고
    • Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways
    • 1:CAS:528:DC%2BD2cXpsl2jurY%3D 15545519
    • Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004;110(21):3335-40.
    • (2004) Circulation , vol.110 , Issue.21 , pp. 3335-3340
    • Calabro, P.1    Samudio, I.2    Willerson, J.T.3    Yeh, E.T.4
  • 84
    • 84856957894 scopus 로고    scopus 로고
    • Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
    • 3276682 1:CAS:528:DC%2BC38Xhs1GgsLc%3D 22297845
    • Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179-85.
    • (2012) Nature , vol.482 , Issue.7384 , pp. 179-185
    • Henao-Mejia, J.1    Elinav, E.2    Jin, C.3    Hao, L.4    Mehal, W.Z.5    Strowig, T.6
  • 85
    • 84859033154 scopus 로고    scopus 로고
    • High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects
    • 3263907 1:CAS:528:DC%2BC38Xjt1aisrw%3D 22210577
    • Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care. 2012;35(2):375-82.
    • (2012) Diabetes Care , vol.35 , Issue.2 , pp. 375-382
    • Harte, A.L.1    Varma, M.C.2    Tripathi, G.3    McGee, K.C.4    Al-Daghri, N.M.5    Al-Attas, O.S.6
  • 86
    • 68949178506 scopus 로고    scopus 로고
    • Endotoxemia and gut barrier dysfunction in alcoholic liver disease
    • 1:CAS:528:DC%2BD1MXhtVKrtrnO 19575462
    • Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. 2009;50(2):638-44.
    • (2009) Hepatology , vol.50 , Issue.2 , pp. 638-644
    • Rao, R.1
  • 87
    • 84873966954 scopus 로고    scopus 로고
    • Role of gut microbiota in liver diseases
    • 1:CAS:528:DC%2BC3sXos1yqsbc%3D 22970713
    • Miyake Y, Yamamoto K. Role of gut microbiota in liver diseases. Hepatol Res. 2013;43(2):139-46.
    • (2013) Hepatol Res , vol.43 , Issue.2 , pp. 139-146
    • Miyake, Y.1    Yamamoto, K.2
  • 88
    • 84867616398 scopus 로고    scopus 로고
    • High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway
    • 3473013 1:CAS:528:DC%2BC38Xhs1Wht7fO 23091640
    • Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012;7(10):e47713.
    • (2012) PLoS One , vol.7 , Issue.10 , pp. e47713
    • Kim, K.A.1    Gu, W.2    Lee, I.A.3    Joh, E.H.4    Kim, D.H.5
  • 89
    • 0033405387 scopus 로고    scopus 로고
    • Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the Bruneck Study
    • Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999;34(7):1975-81.
    • (1999) J Am Coll Cardiol , vol.34 , Issue.7 , pp. 1975-1981
    • Wiedermann, C.J.1    Kiechl, S.2    Dunzendorfer, S.3    Schratzberger, P.4    Egger, G.5    Oberhollenzer, F.6
  • 90
    • 0035928838 scopus 로고    scopus 로고
    • Immunopathogenesis of atherosclerosis: Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet
    • Lehr HA, Sagban TA, Ihling C, Zähringer U, Hungerer KD, Blumrich M, et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001;104(8):914-20.
    • (2001) Circulation , vol.104 , Issue.8 , pp. 914-920
    • Lehr, S.1
  • 91
    • 0344393623 scopus 로고    scopus 로고
    • Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
    • Denecke B, Gräber S, Schäfer C, Heiss A, Wöltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 2003;376(Pt 1):135-45.
    • (2003) Biochem J , vol.376 , pp. 135-145
    • Denecke Gräber B, S.1    Schäfer, C.2    Heiss, A.3    Wöltje, M.4    Jahnen-Dechent, W.5
  • 92
    • 0027333427 scopus 로고
    • Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level
    • Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol. 1993;7(11):1445-55.
    • (1993) Mol Endocrinol , vol.7 , Issue.11 , pp. 1445-1455
    • Srinivas, P.R.1    Wagner, A.S.2    Reddy, L.V.3    Deutsch, D.D.4    Ma, L.5    Goustin, A.S.6
  • 93
    • 84864657351 scopus 로고    scopus 로고
    • Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
    • Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279-85.
    • (2012) Nat Med , vol.18 , Issue.8 , pp. 1279-1285
    • Pal, D.1    Dasgupta, S.2    Kundu, R.3    Maitra, S.4    Das, G.5    Mukhopadhyay, S.6
  • 94
    • 84855302030 scopus 로고    scopus 로고
    • Fetuin-A and the cardiovascular system
    • 1:CAS:528:DC%2BC38XmvVejsLw%3D 22397032
    • Mori K, Emoto M, Inaba M. Fetuin-A and the cardiovascular system. Adv Clin Chem. 2012;56:175-95.
    • (2012) Adv Clin Chem , vol.56 , pp. 175-195
    • Mori, K.1    Emoto, M.2    Inaba, M.3
  • 95
    • 84859440795 scopus 로고    scopus 로고
    • Transforming growth factor-beta and atherosclerosis: Interwoven atherogenic and atheroprotective aspects
    • 1:CAS:528:DC%2BC38XkslektQ%3D%3D 21626289
    • Toma I, McCaffrey TA. Transforming growth factor-beta and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell Tissue Res. 2012;347(1):155-75.
    • (2012) Cell Tissue Res , vol.347 , Issue.1 , pp. 155-175
    • Toma, I.1    McCaffrey, T.A.2
  • 96
    • 84870588845 scopus 로고    scopus 로고
    • Latest advances in sleep medicine: Obstructive sleep apnea
    • 23208337
    • Simon S, Collop N. Latest advances in sleep medicine: obstructive sleep apnea. Chest. 2012;142(6):1645-51.
    • (2012) Chest , vol.142 , Issue.6 , pp. 1645-1651
    • Simon, S.1    Collop, N.2
  • 97
    • 84897869286 scopus 로고    scopus 로고
    • Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome
    • Tock L, Carneiro G, Togeiro SM, Hachul H, Pereira AZ, Tufik S, et al. Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. Endocr Pract. 2014;20(3):244-51.
    • (2014) Endocr Pract , vol.20 , Issue.3 , pp. 244-251
    • Tock Carneiro L, G.1    Togeiro, S.M.2    Hachul, H.3    Pereira, A.Z.4    Tufik, S.5
  • 99
    • 28144434536 scopus 로고    scopus 로고
    • The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence
    • Baguet JP, Hammer L, Lévy P, Pierre H, Launois S, Mallion JM, et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest. 2005;128(5):3407-12.
    • (2005) Chest , vol.128 , Issue.5 , pp. 3407-3412
    • Baguet, J.P.1    Hammer, L.2    Lévy, P.3    Pierre, H.4    Launois, S.5    Mallion, J.M.6
  • 100
    • 24144502902 scopus 로고    scopus 로고
    • Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea
    • Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172(5):625-30.
    • (2005) Am J Respir Crit Care Med , vol.172 , Issue.5 , pp. 625-630
    • Minoguchi, K.1    Yokoe, T.2    Tazaki, T.3    Minoguchi, H.4    Tanaka, A.5    Oda, N.6
  • 101
    • 58049158570 scopus 로고    scopus 로고
    • Obstructive sleep apnoea and its cardiovascular consequences
    • 19101028
    • Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82-93.
    • (2009) Lancet , vol.373 , Issue.9657 , pp. 82-93
    • Bradley, T.D.1    Floras, J.S.2
  • 102
    • 84861985896 scopus 로고    scopus 로고
    • OSA and atherosclerosis
    • 3378220 22833822
    • Lui MM, Sau-Man M. OSA and atherosclerosis. J Thorac Dis. 2012;4(2):164-72.
    • (2012) J Thorac Dis , vol.4 , Issue.2 , pp. 164-172
    • Lui, M.M.1    Sau-Man, M.2
  • 103
    • 11844291275 scopus 로고    scopus 로고
    • Fatty acid-binding proteins as plasma markers of tissue injury
    • 1:CAS:528:DC%2BD2MXkvFansQ%3D%3D 15653098
    • Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352(1-2):15-35.
    • (2005) Clin Chim Acta , vol.352 , Issue.1-2 , pp. 15-35
    • Pelsers, M.M.1    Hermens, W.T.2    Glatz, J.F.3
  • 104
    • 0030855627 scopus 로고    scopus 로고
    • Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
    • 1:CAS:528:DyaK2sXltFyms7w%3D 9267316
    • Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem. 1997;43(8 Pt 1):1372-8.
    • (1997) Clin Chem , vol.43 , Issue.8 , pp. 1372-1378
    • Ishii, J.1    Wang, J.H.2    Naruse, H.3    Taga, S.4    Kinoshita, M.5    Kurokawa, H.6
  • 105
    • 84879076147 scopus 로고    scopus 로고
    • Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis
    • Basar O, Akbal E, Köklü S, Tuna Y, Koçak E, Başar N, et al. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz. 2013;38(4):417-22.
    • (2013) Herz , vol.38 , Issue.4 , pp. 417-422
    • Basar, O.1    Akbal, E.2    Köklü, S.3    Tuna, Y.4    Koçak, E.5    Başar, N.6
  • 106
    • 39049102073 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
    • Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444-50.
    • (2008) Diabetologia , vol.51 , Issue.3 , pp. 444-450
    • Targher, G.1    Bertolini, L.2    Rodella, S.3    Zoppini, G.4    Lippi, G.5    Day, C.6
  • 107
    • 77955665639 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
    • 1:CAS:528:DC%2BC3cXmsFyrtLw%3D 20369224
    • Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia. 2010;53(7):1341-8.
    • (2010) Diabetologia , vol.53 , Issue.7 , pp. 1341-1348
    • Targher, G.1    Bertolini, L.2    Chonchol, M.3    Rodella, S.4    Zoppini, G.5    Lippi, G.6
  • 108
    • 77953838107 scopus 로고    scopus 로고
    • Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
    • 1:CAS:528:DC%2BC3cXpvVemu7Y%3D 19460054
    • Hwang ST, Cho YK, Yun JW, Park JH, Kim HJ, Park DI, et al. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Intern Med J. 2010;40(6):437-42.
    • (2010) Intern Med J , vol.40 , Issue.6 , pp. 437-442
    • Hwang, S.T.1    Cho, Y.K.2    Yun, J.W.3    Park, J.H.4    Kim, H.J.5    Park, D.I.6
  • 109
    • 84890401791 scopus 로고    scopus 로고
    • Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography
    • 1:CAS:528:DC%2BC3sXhvV2rsr7K 24029696
    • Mikolasevic I, Racki S, Bubic I, Jelic I, Stimac D, Orlic L. Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography. Kidney Blood Press Res. 2013;37(4-5):305-10.
    • (2013) Kidney Blood Press Res , vol.37 , Issue.4-5 , pp. 305-310
    • Mikolasevic, I.1    Racki, S.2    Bubic, I.3    Jelic, I.4    Stimac, D.5    Orlic, L.6
  • 110
    • 84890886616 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease; A part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction
    • 1:CAS:528:DC%2BC3sXhvVKisLbK 24280560
    • Mikolasevic I, Racki S, Lukenda V, Pavletic-Persic M, Milic S, Orlic L. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. Med Hypotheses. 2014;82(1):36-9.
    • (2014) Med Hypotheses , vol.82 , Issue.1 , pp. 36-39
    • Mikolasevic, I.1    Racki, S.2    Lukenda, V.3    Pavletic-Persic, M.4    Milic, S.5    Orlic, L.6
  • 111
    • 84867033274 scopus 로고    scopus 로고
    • Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD)
    • Bəloşeanu CL, Streba CT, Vere CC, Comənescu V, Rogoveanu I. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol. 2012;53(3):609-14.
    • (2012) Rom J Morphol Embryol , vol.53 , Issue.3 , pp. 609-614
    • Bəloşeanu, C.L.1    Streba, C.T.2    Vere, C.C.3    Comənescu, V.4    Rogoveanu, I.5
  • 112
    • 84857755330 scopus 로고    scopus 로고
    • Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy
    • 22545359
    • Saleh DA, Ismail MA, Ibrahim AM. Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. Pak J Biol Sci. 2012;15(2):68-77.
    • (2012) Pak J Biol Sci , vol.15 , Issue.2 , pp. 68-77
    • Saleh, D.A.1    Ismail, M.A.2    Ibrahim, A.M.3
  • 113
    • 84868137269 scopus 로고    scopus 로고
    • Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis
    • 22847887
    • Yang YY, Huang YT, Lee TY, Chan CC, Yeh YC, Lee KC, et al. Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis. Liver Transpl. 2012;18(11):1371-83.
    • (2012) Liver Transpl , vol.18 , Issue.11 , pp. 1371-1383
    • Yang, Y.Y.1    Huang, Y.T.2    Lee, T.Y.3    Chan, C.C.4    Yeh, Y.C.5    Lee, K.C.6
  • 114
    • 33644700376 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
    • 1:CAS:528:DC%2BD2MXht12gsL%2FN 16306373
    • Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54(12):3541-6.
    • (2005) Diabetes , vol.54 , Issue.12 , pp. 3541-3546
    • Targher, G.1    Bertolini, L.2    Poli, F.3    Rodella, S.4    Scala, L.5    Tessari, R.6
  • 115
    • 84872688513 scopus 로고    scopus 로고
    • A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
    • 3547443 1:CAS:528:DC%2BC3sXht1Kmsbs%3D 24381427
    • Mishra S, Yadav D, Gupta M, Mishra H, Sharma P. A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. Indian J Clin Biochem. 2013; 28(1):79-83.
    • (2013) Indian J Clin Biochem , vol.28 , Issue.1 , pp. 79-83
    • Mishra, S.1    Yadav, D.2    Gupta, M.3    Mishra, H.4    Sharma, P.5
  • 116
    • 84922069983 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
    • 1:STN:280:DC%2BC2MzjtVKltA%3D%3D 25456154
    • Li N, Zhang GW, Zhang JR, Jin D, Li Y, Liu T, et al. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. Nutr Metab Cardiovasc Dis. 2015; 25(2):218-23.
    • (2015) Nutr Metab Cardiovasc Dis , vol.25 , Issue.2 , pp. 218-223
    • Li, N.1    Zhang, G.W.2    Zhang, J.R.3    Jin, D.4    Li, Y.5    Liu, T.6
  • 117
    • 84861189807 scopus 로고    scopus 로고
    • Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease
    • 22495402
    • Colak Y, Karabay CY, Tuncer I, Kocabay G, Kalayci A, Senates E, et al. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2012; 24(6):613-8.
    • (2012) Eur J Gastroenterol Hepatol , vol.24 , Issue.6 , pp. 613-618
    • Colak, Y.1    Karabay, C.Y.2    Tuncer, I.3    Kocabay, G.4    Kalayci, A.5    Senates, E.6
  • 118
    • 84908519068 scopus 로고    scopus 로고
    • Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness
    • 1:CAS:528:DC%2BC2cXhslyks7zP 25463079
    • Sunbul M, Agirbasli M, Durmus E, Kivrak T, Akin H, Aydin Y, et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis. 2014; 237(2):490-3.
    • (2014) Atherosclerosis , vol.237 , Issue.2 , pp. 490-493
    • Sunbul, M.1    Agirbasli, M.2    Durmus, E.3    Kivrak, T.4    Akin, H.5    Aydin, Y.6
  • 119
    • 84859954406 scopus 로고    scopus 로고
    • Fatty liver index, gamma-glutamyltransferase, and early carotid plaques
    • 1:CAS:528:DC%2BC38Xlslyisr0%3D 22334565
    • Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012; 55(5):1406-15.
    • (2012) Hepatology , vol.55 , Issue.5 , pp. 1406-1415
    • Kozakova, M.1    Palombo, C.2    Eng, M.P.3    Dekker, J.4    Flyvbjerg, A.5    Mitrakou, A.6
  • 120
    • 77954315951 scopus 로고    scopus 로고
    • Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis
    • 1:CAS:528:DC%2BC3cXos1yitLg%3D 20181335
    • Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis. 2010; 211(1):182-6.
    • (2010) Atherosclerosis , vol.211 , Issue.1 , pp. 182-186
    • Yilmaz, Y.1    Kurt, R.2    Yonal, O.3    Polat, N.4    Celikel, C.A.5    Gurdal, A.6
  • 121
    • 78049523237 scopus 로고    scopus 로고
    • Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease
    • 20890890
    • Pacifico L, Anania C, Martino F, Cantisani V, Pascone R, Marcantonio A, et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology. 2010; 52(5):1643-51.
    • (2010) Hepatology , vol.52 , Issue.5 , pp. 1643-1651
    • Pacifico, L.1    Anania, C.2    Martino, F.3    Cantisani, V.4    Pascone, R.5    Marcantonio, A.6
  • 122
    • 79959453955 scopus 로고    scopus 로고
    • Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
    • 3234131 1:CAS:528:DC%2BC3MXns1Sgur4%3D 22162978
    • Alkhouri N, Carter-Kent C, Elias M, Feldstein AE. Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clin Lipidol. 2011; 6(3):305-314.
    • (2011) Clin Lipidol , vol.6 , Issue.3 , pp. 305-314
    • Alkhouri, N.1    Carter-Kent, C.2    Elias, M.3    Feldstein, A.E.4
  • 123
    • 23044512117 scopus 로고    scopus 로고
    • Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
    • 15981216
    • Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005; 42(2):473-80.
    • (2005) Hepatology , vol.42 , Issue.2 , pp. 473-480
    • Villanova, N.1    Moscatiello, S.2    Ramilli, S.3    Bugianesi, E.4    Magalotti, D.5    Vanni, E.6
  • 124
    • 84931025373 scopus 로고    scopus 로고
    • Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis
    • 25603326
    • Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev Esp Enferm Dig. 2015; 107(1):10-6.
    • (2015) Rev Esp Enferm Dig , vol.107 , Issue.1 , pp. 10-16
    • Ampuero, J.1    Gallego-Durán, R.2    Romero-Gómez, M.3
  • 125
    • 84892775883 scopus 로고    scopus 로고
    • Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease
    • 24377153
    • Guleria A, Duseja A, Kalra N, Das A, Dhiman R, Chawla Y, et al. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop Gastroenterol. 2013; 34(2):74-82.
    • (2013) Trop Gastroenterol , vol.34 , Issue.2 , pp. 74-82
    • Guleria, A.1    Duseja, A.2    Kalra, N.3    Das, A.4    Dhiman, R.5    Chawla, Y.6
  • 126
    • 84949651681 scopus 로고    scopus 로고
    • Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease
    • 25910377
    • Torun E, Aydln S, Gökçe S, Özgen ̄T, Donmez T, Cesur Y. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease. Turk J Gastroenterol. 2014; 25 Suppl 1:92-8.
    • (2014) Turk J Gastroenterol. , vol.25 , pp. 92-98
    • Torun, E.1    Aydln, S.2    Gökçe, S.3    Özgen, I.T.4    Donmez, T.5    Cesur, Y.6
  • 127
    • 84929337565 scopus 로고    scopus 로고
    • Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease
    • 1:CAS:528:DC%2BC2MXnvFCju7w%3D 25988358
    • Chen Y, Xu M, Wang T, Sun J, Sun W, Xu B, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015; 241(1):145-50.
    • (2015) Atherosclerosis , vol.241 , Issue.1 , pp. 145-150
    • Chen, Y.1    Xu, M.2    Wang, T.3    Sun, J.4    Sun, W.5    Xu, B.6
  • 128
    • 84927130329 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men
    • 1:CAS:528:DC%2BC2MXmsFSis7g%3D 25875390
    • Ozturk K, Uygun A, Guler AK, Demirci H, Ozdemir C, Cakir M, et al. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. Atherosclerosis. 2015; 240(2):380-6.
    • (2015) Atherosclerosis , vol.240 , Issue.2 , pp. 380-386
    • Ozturk, K.1    Uygun, A.2    Guler, A.K.3    Demirci, H.4    Ozdemir, C.5    Cakir, M.6
  • 129
    • 84928586324 scopus 로고    scopus 로고
    • Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors
    • 25776455
    • Pastori D, Loffredo L, Perri L, Baratta F, Scardella L, Polimeni L, et al. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. Am J Cardiol. 2015; 115(10):1402-6.
    • (2015) Am J Cardiol , vol.115 , Issue.10 , pp. 1402-1406
    • Pastori, D.1    Loffredo, L.2    Perri, L.3    Baratta, F.4    Scardella, L.5    Polimeni, L.6
  • 130
    • 84937114987 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity
    • Puig J, Blasco G, Daunis-I-Estadella J, Loshuertos E, Codina J, Cuba V, et al. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clin Endocrinol (Oxf). 2015; 83(2):180-6.
    • (2015) Clin Endocrinol (Oxf) , vol.83 , Issue.2 , pp. 180-186
    • Puig, J.1    Blasco, G.2    Daunis-I-Estadella, J.3    Loshuertos, E.4    Codina, J.5    Cuba, V.6
  • 131
    • 84899924674 scopus 로고    scopus 로고
    • Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance
    • 1:CAS:528:DC%2BC2cXoslOmt7s%3D 24512497
    • Kim SK, Choi YJ, Huh BW, Park SW, Lee EJ, Cho YW, et al. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab. 2014; 99(5):1879-84.
    • (2014) J Clin Endocrinol Metab , vol.99 , Issue.5 , pp. 1879-1884
    • Kim, S.K.1    Choi, Y.J.2    Huh, B.W.3    Park, S.W.4    Lee, E.J.5    Cho, Y.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.